Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pegunigalsidase alfa

pegunigalsidase alfa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Elfabrio SOLUTION, INTRAVENOUS 5 mg/2.5 mL, 20 mg/10 mL      
VIEW MORE Enzymes
CLASS
440000
Comments:

Non-formulary. Use is expected to be rare. Defer use to non-hospital outpatient setting

 

 

 

 

Reviewed: August 2025

 

Pegunigalsidase alfa (ELFABRIO) Spotlight.pdf

Last updated: Sep. 10, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved